Images List Premium Download Classic

Immune Disease

Immune Disease-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Automated immunoanalyzer system for performing diagnostic assays for autoimmune and infectious diseases
Hycor Biomedical, Llc
July 20, 2017 - N°20170205410

A quantitative method for diagnosing an autoimmune disease or an infectious disease comprising performing an automated diagnostic assay, comprising: incubating a capture reagent with a streptavidin-coated medium to form a solid phase complex, wherein the capture reagent is a biotinylated autoantigen or infectious disease antigen; washing the solid phase complex to remove excess capture reagent; incubating the solid phase complex ...
Molecules with specificity for cd45 and cd79
Ucb Biopharma Sprl
July 20, 2017 - N°20170204183

The present disclosure relates to a multispecific molecule comprising a binding domain specific to the antigen cd45 and a binding domain specific to the antigen cd79a and/or cd79b, compositions comprising same and use of each in treatment, for example treatment of autoimmune disease.
Anti-ilt7 antibody
Sbi Biotech Co., Ltd.
July 20, 2017 - N°20170204179

An antibody binding to ipc was obtained by using an animal cell in which a cell membrane protein associatable with ilt7 was co-expressed as an immunogen. The antibody of the invention has a high specificity which allows immunological distinction between other ilt family molecules and ilt7. The anti-ilt7 antibody of the invention bound to ipc and inhibited the activity thereof. ...
Immune Disease Patent Pack
Download 255+ patent application PDFs
Immune Disease Patent Applications
Download 255+ Immune Disease-related PDFs
For professional research & prior art discovery
inventor
  • 255+ full patent PDF documents of Immune Disease-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Molecules that selectively activate regulatory t cells for the treatment of autoimmune diseases
Delinia, Inc.
July 20, 2017 - N°20170204154

This invention provides for a fusion protein between an il2αβγ selective agonist protein (il2 selective agonist) and a igg fc protein using a linker. The il2 selective agonist moiety provides a therapeutic activity by selectively activating the il2αβγ form of the receptor, thus selectively stimulating tregs. The fc ...
Method of designing a peptide and/or peptide derivative for modulating gamma-c-cytokine activity
Bioniz, Llc
July 20, 2017 - N°20170204153

The γc-family cytokines, interleukin-2 (il-2), interleukin-4 (il-4), interleukin-7 (il-7), interleukin-9 (il-9), interleukin-15 (il-15), and interleukin-21 (il-21), are associated with important human diseases, such as leukemia, autoimmune diseases, collagen diseases, diabetes mellitus, skin diseases, degenerative neuronal diseases and graft-versus-host disease (gvhd). Thus, inhibitors of γc-cytokine activity are valuable therapeutic and cosmetic agents as well as research tools. ...
An isolated interleukin-34 polypeptide for use in preventing transplant rejection and treating autoimmune diseases
UniversitÉ De Nantes
July 20, 2017 - N°20170202921

The invention relates to an isolated interleukin-34 (il-34) polypeptide for use in preventing or treating graft rejection, autoimmune disease, unwanted immune response against therapeutic proteins and allergy. The invention also provides an in vitro method for determining whether a patient is at risk of transplant rejection, autoimmune diseases, unwanted immune response against therapeutic proteins or allergies, comprising a step of ...
Immune Disease Patent Pack
Download 255+ patent application PDFs
Immune Disease Patent Applications
Download 255+ Immune Disease-related PDFs
For professional research & prior art discovery
inventor
  • 255+ full patent PDF documents of Immune Disease-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Small molecule inhibitors of stat3 with anti-tumor activity
University Of Central Florida Research Foundation.
July 20, 2017 - N°20170202795

The present invention concerns compounds, compositions containing these compounds, and methods of using these compounds and compositions as inhibitors of stat3 signaling, stat3 dimerization, stat3-dna binding, stat5-dna binding, and/or aberrant cell growth in vitro or in vivo, e. G., as anti-cancer agents for treatment of cancer, such as breast cancer. The compounds of the invention include, but ...
Marker sequences for diagnosing and stratifying systemic sclerosis patients
Protagen Ag
July 13, 2017 - N°20170199202

The present invention relates to methods for identifying markers for systemic sclerosis (also scleroderma; ssc) and to the markers identified with the aid of this method, which can differentiate between ssc and other autoimmune diseases on the one hand and between different ssc subgroups on the other hand. The invention also relates to panels, diagnostic devices and test kits which ...
Compositions and methods for the diagnosis of systemic autoimmune disease
Inova Diagnostics, Inc.
July 13, 2017 - N°20170199187

The present disclosure relates to the field of molecular biology and immunology. More specifically, the present disclosure provides compositions and methods for detecting anti-th/to autoantibodies in the serum of subject with a systemic autoimmune disease, such as systemic sclerosis (ssc).
Methods of using cells associated with autoimmune disease
Singapore Health Services Pte Ltd.
July 13, 2017 - N°20170199186

The present invention relates to methods of diagnosing autoimmune disease, predicting suitable treatments of autoimmune disease or identifying autoantigens of autoimmune disease using a population of immunogenic hla-dr+ t cells.
Novel combinations for antigen based therapy
Diamyd Medical Ab
July 13, 2017 - N°20170196949

The present invention relates to a method for prevention and/or treatment of an autoimmune disease, comprising administering a composition, said composition comprising at least one beta cell autoantigen, to a subject the subject may have a serum vitamin-d level above 50 nanomole/liter or the composition may be administered by intralymphatic injection or injection directly into a lymph node, or ...
Mth1 inhibitors for treatment of inflammatory and autoimmune conditions
Thomas Helledays Stiftelse For Medicinsk Forskning
July 13, 2017 - N°20170196873

A compound of formula (i), or a pharmaceutically acceptable salt thereof, for use in the treatment of autoimmune diseases and inflammatory conditions.
Treatment of autoimmune disease
Mingsight Pharmaceuticals, Inc.
July 13, 2017 - N°20170196865

Provided herein are compositions and methods for the treatment of autoimmune diseases, including lupus, uveitis and encephalitis. Said compositions useful for treating autoimmune diseases comprise pyrrolo-pyrazole pkc inhibitors.
Immune Disease Patent Pack
Download 255+ patent application PDFs
Immune Disease Patent Applications
Download 255+ Immune Disease-related PDFs
For professional research & prior art discovery
inventor
  • 255+ full patent PDF documents of Immune Disease-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Alpha1 -antitrypsin compositions and methods of treating autoimmune diseases
Beth Israel Deaconess Medical Center, Inc.
July 06, 2017 - N°20170190762

The specification provides compositions comprising chimeric proteins comprising aat conjugated to an fc region of an immunoglobulin. Methods for treating autoimmune disease, e. G., diabetes, e. G., type 1 and type 2 diabetes, are also provided.
Pyridine and pyridimine compounds as pi3k-gamma inhibitors
Incyte Corporation
July 06, 2017 - N°20170190689

The present disclosure provides compounds of formula i, or pharmaceutically acceptable salts thereof, that modulate the activity of phosphoinositide 3-kinases-gamma (pi3kγ) and are useful in the treatment of diseases related to the activity of pi3kγ including, for example, autoimmune diseases, cancer, cardiovascular diseases, and neurodegenerative diseases.
Use of kukoamine a and kukoamine b
The First Affiliated Hospital, Third Military Medical University, Pla
July 06, 2017 - N°20170189355

The use of kukoamine a and kukoamine b in the preparation of drugs for the prevention and treatment of sepsis and autoimmune disease is disclosed. Bacterial endotoxin/lipopolysaccaride (lps) and unmethylated dna (cpg dna) of bacteria, the major pathogen-associated molecular patterns in sepsis and autoimmune disease, are specifically targeted, while the disclosed use and directionally isolates lead compounds from traditional ...
Dd1alpha receptor and uses thereof in immune disorders
The General Hospital Corporation
June 29, 2017 - N°20170184604

Described herein are methods and compositions for treatment of immune-related diseases or disorders by modulating dd1α activity, alone or in combination with modulation of pd-1 activity. In some embodiments, the methods and compositions described herein are directed to treatment of cancer and/or infections (e. G., bacterial infection, and/or fungal infection). In some embodiments, the methods and ...
Compositions and methods for autoimmune disease
Nodality, Inc.
June 29, 2017 - N°20170184587

Methods and compositions are described for categorizing and treating autoimmune disease, using single cell network profiling (scnp), where activation levels of one or more activatable elements are determined in single cells, with or without modulation, to categorize or determine treatment for the autoimmune disease.
Inhibitors of cyclin-dependent kinase 7 (cdk7)
Syros Pharmaceuticals, Inc.
June 29, 2017 - N°20170183355

The present invention provides novel compounds of formula (i) and formula (ii) and pharmaceutically acceptable salts, solvates, hydrates, tautomers, stereoisomers, isotopically labeled derivatives, and compositions thereof. Also provided are methods and kits involving the compounds or compositions for treating or preventing proliferative diseases (e. G., cancers (e. G., leukemia, melanoma, multiple myeloma), benign neoplasms, angiogenesis, inflammatory diseases, autoinflammatory diseases, and ...
Pyrrolopyrimidine compounds and their uses
Astex Therapeutics Ltd.
June 29, 2017 - N°20170183352

The disclosed compounds relate to treatments and therapies for protein kinase-associated disorders. There is also a need for compounds useful in the treatment or prevention or amelioration of one or more symptoms of cancer, transplant rejections, and autoimmune diseases. Furthermore, there is a need for methods for modulating the activity of protein kinases, such as cdk1, cdk2, cdk4, cdk5, cdk6, ...
Autoantibody detection method, method for testing possibility of autoimmune disease contraction, autoantibody detection reagent, and ...
Osaka University
June 22, 2017 - N°20170176432

The present invention provides an autoantibody detection method that can detect an autoantibody causing an autoimmune disease with high accuracy. The autoantibody detection method of the present invention includes the steps of; causing a sample and an antigen reagent comprising a denatured protein presented by an mhc class ii molecule to come into contact with each other; and detecting a ...
Loading